Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

Psychogeriatrics is a leading peer-reviewed journal published by WILEY, dedicated to advancing the understanding of mental health and geriatric psychiatry. With an ISSN of 1346-3500 and an E-ISSN of 1479-8301, this journal has been integral to the field since its inception in 2005 and continues to publish cutting-edge research until 2024. Recognized for its impact, Psychogeriatrics holds a commendable Q2 quartile ranking in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health as of 2023. The journal's Scopus rankings reflect its significant contribution to Nursing Gerontology, Medicine Psychiatry and Mental Health, and Medicine Geriatrics and Gerontology. Although it operates with no open access options, Psychogeriatrics remains a vital resource for researchers, professionals, and students who are exploring the complexities of mental health in older populations. The journal not only disseminates innovative research but also tackles pressing issues related to the psychological well-being of the elderly, making it essential reading for anyone focused on improving geriatric mental health care.

Schizophrenia Research is a premier academic journal focused on innovative research within the domain of psychiatry and mental health, published by Elsevier. With its ISSN 0920-9964 and E-ISSN 1573-2509, the journal has established a strong presence since its inception in 1988, evolving to publish cutting-edge findings up to 2024. Positioned in Q1 in Psychiatry and Mental Health and Q2 in Biological Psychiatry, it ranks impressively in the 83rd percentile among its peers, according to Scopus, ranking #93/567 in the field of Medicine, and #12/51 in Neuroscience. This journal serves as a vital platform for the dissemination of significant scientific advancements and theoretical insights into schizophrenia, fostering a deeper understanding of mental illnesses. Although it operates on a subscription basis, its critical role in informing both ongoing research and clinical practices cannot be overstated, making it an essential resource for researchers, clinicians, and students alike. Join a global community dedicated to improving mental health outcomes and advancing the study of schizophrenia through this reputable publication.

International Journal of Gerontology is a distinguished peer-reviewed journal dedicated to advancing the field of gerontology and addressing the multifaceted challenges associated with aging. Published by the Taiwan Society of Geriatric Emergency & Critical Care Medicine, this innovative journal has been an open-access platform since 2018, ensuring that vital research is accessible to a global audience. With an ISSN of 1873-9598, it serves as a crucial resource for researchers and practitioners focused on the biological, psychological, and social aspects of aging. The journal is indexed in Scopus with a rank of #103/116 in the Medicine category (Geriatrics and Gerontology) as of 2023, placing it in the Q4 quartile—a testament to its evolving impact in the field. Spanning works published from 2007 to 2024, the International Journal of Gerontology facilitates the dissemination of critical research findings and clinical practices that inform and enhance geriatric care and research methodologies.

Alzheimers & Dementia is a premier journal published by WILEY that focuses on the latest advancements in understanding, diagnosing, and treating Alzheimer's disease and other dementias. With an ISSN of 1552-5260 and an E-ISSN of 1552-5279, this influential journal boasts a commendable impact factor and ranks in the Q1 category across several disciplines, including *Cellular and Molecular Neuroscience*, *Geriatrics and Gerontology*, and *Neurology (Clinical)*. By publishing cutting-edge research, systematic reviews, and innovative clinical trials, Alzheimers & Dementia aims to bridge the gap between basic neuroscience and clinical practice, offering valuable insights into the etiology, epidemiology, and management of dementia-related disorders. The journal is hosted in the United States and operates under a balanced access model, providing essential resources for researchers, healthcare professionals, and students dedicated to tackling the challenges posed by these neurodegenerative diseases. Available online, it plays a pivotal role in shaping current and future research directions in the vibrant field of dementia studies.

Advances in Gerontology is a pivotal academic journal dedicated to the field of gerontology, published by PLEIADES PUBLISHING INC. With its ISSN 2079-0570 and E-ISSN 2079-0589, this journal serves as an essential platform for researchers, healthcare professionals, and students focused on aging and related health issues. Although currently not an open-access journal, it aspires to enrich the scholarly community by disseminating high-quality research from 2011 through 2024. The journal is recognized in the lower quartile of its category, ranking Q4 in both Geriatrics and Gerontology, reflecting its commitment to addressing emerging topics in the aging population despite its lower visibility in the competitive landscape. As it continues to explore critical areas in gerontology, Advances in Gerontology invites contributions that advance knowledge, foster understanding, and inform practices within this essential field of study.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.

Neurodegenerative Disease Management is a distinguished journal published by FUTURE MEDICINE LTD, focusing on the pivotal issues surrounding the management of neurodegenerative diseases. Since its inception in 2014, this journal has emerged as a significant resource within the fields of medicine and neurology, currently holding a respected position with a Q2 category ranking in Medicine (miscellaneous) and Q3 in Neurology (clinical) for 2023. With an ISSN of 1758-2024 and E-ISSN 1758-2032, the journal provides a platform for the dissemination of innovative research, clinical practices, and advancements in treatment strategies for conditions such as Alzheimer's, Parkinson's, and multiple sclerosis. The journal is particularly committed to enhancing knowledge sharing among researchers, health professionals, and students, contributing to the collective effort in combatting neurodegenerative diseases. Though not open access, its articles are meticulously curated to ensure high-quality, impactful contributions to the field, making it an essential reference for those engaged in neurology and related disciplines.

Australasian Journal on Ageing, published by Wiley, is a leading academic journal dedicated to advancing the understanding of ageing processes and promoting health and well-being in older populations. With an ISSN of 1440-6381 and E-ISSN 1741-6612, this journal serves as a vital resource for researchers and practitioners in the fields of Community and Home Care, Geriatrics and Gerontology, and broader Medical disciplines. Since its inception in 1998, the journal has showcased high-quality research and innovative approaches to the challenges of ageing, as evidenced by its Q2 and Q3 rankings across relevant categories in 2023. With a focus on practical implications and interdisciplinary collaboration, the Australasian Journal on Ageing is instrumental in shaping policies and practices that enhance the quality of life for older adults. Notably, it is ranked highly in the Nursing community and maintains a strong position in geriatric research, making it an essential outlet for scholarly work that influences real-world outcomes.

American Journal of Geriatric Psychiatry, published by Elsevier Science Inc, stands as a leading journal in the fields of geriatrics and gerontology, as well as psychiatry and mental health, recognized with a Q1 ranking in both categories for 2023. With a robust ISSN of 1064-7481 and E-ISSN 1545-7214, this journal has been a vital resource since its inception in 1993, contributing to the academic discourse surrounding the mental health of older adults. The journal focuses on publishing high-quality research and reviews that address the complexities of psychiatric disorders in geriatric populations, making it essential reading for researchers, professionals, and students dedicated to enhancing the mental well-being of elderly individuals. Notably, it achieves impressive Scopus rankings, sitting at the 5th percentile in Geriatrics and Gerontology and 24th percentile in Psychiatry and Mental Health, underscoring its impact and relevance in the academic community. While it does not offer open access, the journal's comprehensive content is vital for those looking to stay informed on the latest advancements in geriatric psychiatry. For more information, readers can access it via Elsevier's educational platforms.